pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Heritage Pharmaceuticals Inc

updated 2mo ago

Heritage Pharmaceuticals Inc. is a manufacturer of generic pharmaceuticals based in Eatontown, New Jersey, United States, and established in 2006.

community read0 votes

🐶 often sniffed alongside

top 2
  • tagRecall6 co-mentions · 6 sources
  • drugDESIPRAMINE HYDROCHLORIDE6 co-mentions · 6 sources
pipeline
5
marketed
5
phase 3
0
catalysts ytd
2
approvals ytd
2
recalls ytd
0

Pipeline(5)

pipeline depth5 products
Marketed: 5
5Marketed
Marketed
(glyburide + metformin hydrochloride)
Type 2 Diabetes
Marketed
adenosine
Paroxysmal Ventricular Tachycardia
Marketed
diflunisal
Osteoarthritis Pain
Marketed
isosorbide mononitrate PR
Angina (Angina Pectoris)
Marketed
rasagiline
Parkinson's Disease

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Heritage Pharmaceuticals Inc jobs →

News

  • STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with states
    Sandoz agreed to pay $478.5 million to settle allegations that the company engaged in a conspiracy to artificially inflate and manipulate prices.
    stat · 17d ago
  • STAT+: Glenmark to pay $29.6 million to settle price-fixing allegations in long-running battle with states
    Glenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens of states.
    stat · 1mo ago
identifiers
source
globaldata
top tags
Cardiology1Pain1Parkinson's Disease1Type 2 Diabetes1
mentioned in
2news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?